Terrence W. Norchi, PRESIDENT AND CHIEF EXECUTIVE at Arch Therapeutics, Inc. (ARTH), bought 6,862 shares at $0.28 ($2K) on 2023-08-31, disclosed to the SEC on 2023-09-08.
Open-market purchase of $2k ARTH by PRESIDENT AND CHIEF EXECUTIVE. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.